Trial Profile
A Phase II, Randomized, Double-Blind, Parallel Group, Acyclovir-Controlled Study to Evaluate ZEP-3 Ointment for the Treatment of Cold Sores (Herpes Labialis).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs ZEP 3 (Primary) ; Aciclovir
- Indications Herpes labialis
- Focus Adverse reactions; Therapeutic Use
- Sponsors SIS Shulov Innovative Science
- 28 May 2019 Status changed from active, no longer recruiting to completed.
- 17 Apr 2018 Planned End Date changed from 1 Oct 2016 to 1 Jun 2018.
- 17 Apr 2018 Planned primary completion date changed from 1 Sep 2016 to 1 Jun 2018.